150 related articles for article (PubMed ID: 32860385)
1. Trichosporon Asahii fungaemia in an immunocompetent polytrauma patient who received multiple antibiotics.
Ding CH; Khaithir TMN; Wahab AA; Faiz MA; Saarah WR
Malays J Pathol; 2020 Aug; 42(2):293-296. PubMed ID: 32860385
[TBL] [Abstract][Full Text] [Related]
2. The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin.
Mariné M; Bom VL; de Castro PA; Winkelstroter LK; Ramalho LN; Brown NA; Goldman GH
Virulence; 2015; 6(5):476-86. PubMed ID: 25751127
[TBL] [Abstract][Full Text] [Related]
3. Successful Treatment of Breakthrough Trichosporon asahii Fungemia by the Combination Therapy of Fluconazole and Liposomal Amphotericin B in a Patient with Follicular Lymphoma.
Itoh K; Iwasaki H; Negoro E; Shigemi H; Tokimatsu I; Tsutani H; Yamauchi T
Mycopathologia; 2021 Mar; 186(1):113-117. PubMed ID: 33389484
[TBL] [Abstract][Full Text] [Related]
4. Disseminated Trichosporon asahii infection in a combined liver-kidney transplant recipient successfully treated with voriconazole.
Sah R; Soin AS; Chawla S; Wadhwa T; Gupta N
Immun Inflamm Dis; 2019 Sep; 7(3):125-129. PubMed ID: 31006179
[TBL] [Abstract][Full Text] [Related]
5. Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
Sun W; Su J; Xu S; Yan D
J Med Microbiol; 2012 Dec; 61(Pt 12):1750-1757. PubMed ID: 22956749
[TBL] [Abstract][Full Text] [Related]
6. Species distribution and antifungal susceptibility of 358 Trichosporon clinical isolates collected in 24 medical centres.
Francisco EC; de Almeida Junior JN; de Queiroz Telles F; Aquino VR; Mendes AVA; de Andrade Barberino MGM; de Tarso O Castro P; Guimarães T; Hahn RC; Padovan ACB; Chaves GM; Colombo AL
Clin Microbiol Infect; 2019 Jul; 25(7):909.e1-909.e5. PubMed ID: 30991116
[TBL] [Abstract][Full Text] [Related]
7. Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin.
Bayramoglu G; Sonmez M; Tosun I; Aydin K; Aydin F
Infection; 2008 Feb; 36(1):68-70. PubMed ID: 17882360
[TBL] [Abstract][Full Text] [Related]
8. Endogenous Trichosporon Asahii Retinitis.
Parrozzani R; Marchione G; Midena G
Ophthalmology; 2022 Jan; 129(1):66. PubMed ID: 34930551
[No Abstract] [Full Text] [Related]
9. Implication of efflux pumps and
Abbes S; Sellami H; Neji S; Trabelsi H; Makni F; Ayadi A
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33688802
[No Abstract] [Full Text] [Related]
10. Intergenic spacer (IGS-1) region sequence-based identification, genotypic analysis, and antifungal susceptibility of clinical Trichosporon species.
Parashar A; Rastogi V; Prakash H; Pandey A; Rudramurthy SM
Indian J Med Microbiol; 2023; 45():100390. PubMed ID: 37573054
[TBL] [Abstract][Full Text] [Related]
11. A novel silkworm infection model with fluorescence imaging using transgenic Trichosporon asahii expressing eGFP.
Matsumoto Y; Yamazaki H; Yamasaki Y; Tateyama Y; Yamada T; Sugita T
Sci Rep; 2020 Jul; 10(1):10991. PubMed ID: 32620930
[TBL] [Abstract][Full Text] [Related]
12. The epidemiology, genotypes, antifungal susceptibility of Trichosporon species, and the impact of voriconazole on Trichosporon fungemia patients.
Kuo SH; Lu PL; Chen YC; Ho MW; Lee CH; Chou CH; Lin SY
J Formos Med Assoc; 2021 Sep; 120(9):1686-1694. PubMed ID: 33358563
[TBL] [Abstract][Full Text] [Related]
13. Fatal Disseminated Infection by Trichosporon asahii Under Voriconazole Therapy in a Patient with Acute Myeloid Leukemia: A Review of Breakthrough Infections by Trichosporon spp.
Ramírez I; Moncada D
Mycopathologia; 2020 Apr; 185(2):377-388. PubMed ID: 31853871
[TBL] [Abstract][Full Text] [Related]
14. Isolation and antifungal susceptibility testing of Trichosporon asahii in Ceará, Brazil.
Menezes EA; Marinho JA; Angelo MR; Cunha Mda C; Cunha FA; Vasconcelos Júnior AA
Rev Inst Med Trop Sao Paulo; 2012; 54(1):1-3. PubMed ID: 22370746
[TBL] [Abstract][Full Text] [Related]
15. Multiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin B.
Iturrieta-González IA; Padovan AC; Bizerra FC; Hahn RC; Colombo AL
PLoS One; 2014; 9(10):e109553. PubMed ID: 25360765
[TBL] [Abstract][Full Text] [Related]
16. [Fungemia due to Trichosporon asahii in a patient with hematological malignancy].
Odero V; Galán-Sánchez F; García-Agudo L; García-Tapia AM; Guerrero-Lozano I; Rodríguez-Iglesias MA
Rev Iberoam Micol; 2015; 32(1):59-61. PubMed ID: 24071639
[TBL] [Abstract][Full Text] [Related]
17. Micafungin Breakthrough Fungemia in Patients with Hematological Disorders.
Kimura M; Araoka H; Yamamoto H; Nakamura S; Nagi M; Yamagoe S; Miyazaki Y; Ogura S; Mitsuki T; Yuasa M; Kaji D; Kageyama K; Nishida A; Taya Y; Shimazu H; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Wake A; Taniguchi S; Yoneyama A
Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530846
[TBL] [Abstract][Full Text] [Related]
18. Trichosporon asahii causing subcutaneous mycoses in an immunocompetent patient: case report and a minireview.
Kruschewsky WLL; Massaroni-Peçanha P; Maifrede SB; Leite MS; Pôssa TAL; Alberto-Lei F; Cayô R; Peçanha PM; Gonçalves SS
Braz J Microbiol; 2022 Sep; 53(3):1221-1229. PubMed ID: 35378689
[TBL] [Abstract][Full Text] [Related]
19. Trichosporon asahii superinfections in critically ill COVID-19 patients overexposed to antimicrobials and corticosteroids.
Nobrega de Almeida J; Moreno L; Francisco EC; Noronha Marques G; Mendes AV; Barberino MG; Colombo AL
Mycoses; 2021 Aug; 64(8):817-822. PubMed ID: 34091966
[TBL] [Abstract][Full Text] [Related]
20. Complicated Trichosporon asahii mastoiditis in immunocompetent child.
Al Momani M; Yusef DH; Hamasha D; Hamad MRA; Farran S
BMC Infect Dis; 2021 Dec; 21(1):1229. PubMed ID: 34876058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
